B-cell neoplasms differ widely in terms of their molecular and genetic features, tumour grade, aggressiveness, and cell-type, all of which can drastically alter disease course and subsequent treatment response. Healthcare professionals must take into consideration the heterogeneity of these tumours while deciding on the course of treatment. In this KOL commentary, Dr Jessica Okosun provides […]